News Daily News Aging, Angina, and Invasive Management: Some Nuance From ISCHEMIA Shelley Wood April 25, 2023
News Daily News New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF L.A. McKeown April 19, 2023
News Daily News Ezetimibe Plus Moderate-Dose Statins May Aid Compliance in the Elderly Yael L. Maxwell April 03, 2023
News Daily News PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI L.A. McKeown March 29, 2023
News Daily News Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data Michael O'Riordan March 29, 2023
News Conference News THT 2023 REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests Yael L. Maxwell March 22, 2023
News Daily News Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF Todd Neale March 15, 2023
News Conference News ACC 2023 IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF L.A. McKeown March 14, 2023
News Conference News ACC 2023 Wearable Device Helps HF Patients Avoid Coming Back to the Hospital: BMAD Caitlin E. Cox March 06, 2023
News Daily News SCAI Updates Position on Doing PCI Without Surgical Backup Michael O'Riordan February 20, 2023
News Daily News Acute Cardiac Events More Common in COVID-19 Patients With Heart Histories Caitlin E. Cox February 10, 2023
News Daily News Total Meals, Not Timing, Drives Long-term Body Weight Changes Todd Neale January 24, 2023
News Daily News Meeting WHO’s Sodium Benchmarks Would Cut Deaths, Illness, Model Suggests L.A. McKeown January 10, 2023
News Daily News ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly L.A. McKeown December 22, 2022
News Daily News ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA Todd Neale December 16, 2022
News Daily News Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths Michael O'Riordan December 08, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2022 Caitlin E. Cox December 01, 2022
News Conference News AHA 2022 EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD Todd Neale November 06, 2022